EyeCon 2026 Banner
|Articles|December 1, 2006

Case report highlights rationale for neovascular glaucoma treatment

Denver-Intravitreal bevacizumab (Avastin, Genentech) proved to be a successful treatment in a patient with neovascular glaucoma.


Latest CME